{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-069792","form_type":"8-K","ticker":null,"cik":"0001567892","company_name":"Keenova Therapeutics plc","filed_at":"2026-06-03T11:25:30+00:00","discovered_at":"2026-06-03T11:30:00.276090+00:00","generated_at":"2026-06-03T11:30:06.051843+00:00","sec_items":["5.07"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keenova shareholders elect all 9 director nominees, approve all proposals at annual meeting","bullets":["All 9 director nominees elected to hold office until 2027 AGM; average ~25.2M votes 'For' per nominee.","PricewaterhouseCoopers LLP re-appointed as independent auditor with 25.6M 'For' votes.","Say-on-pay approved (25.0M 'For' vs 0.3M 'Against'); frequency set to 1 year.","Special resolutions passed: capital reduction (25.3M 'For') and articles of association amendment (25.5M 'For')."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069792","json":"https://secwatch.observer/filing/0001104659-26-069792.json","markdown":"https://secwatch.observer/filing/0001104659-26-069792.md","text":"https://secwatch.observer/filing/0001104659-26-069792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/tm2616735d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:30:06.051843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7cafe2e6e650b196b9c1c9bc39fbbfd536c84b5a","claim":"Keenova Therapeutics plc shareholders approved Election of directors to hold office until the 2027 Annual General Meeting at the 2026-06-02 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES Paul M. Bisaro 25,282,713 8,884 191,295 310,829","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"80a48330190981fe686a89f5c8f68cf751846451","claim":"Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the frequency of future advisory non-binding votes to approve the Company's executive compensation at the 2026-06-02 meeting.","evidence_excerpt":"1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTES 25,117,919 172,952 726 191,295 310,829","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"81b53102ceff948c9108873e471393d9f39ba859","claim":"Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the re-appointment of PricewaterhouseCoopers LLP as independent auditors and to authorize the Audit Committee to set the auditors’ remuneration at the 2026-06-02 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 25,602,426 0 191,295 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"aa70588b1a428cd627bc7aee242d5ecf51832842","claim":"Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the Company's executive compensation at the 2026-06-02 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 24,965,301 326,296 191,295 310,829","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"b8e31d8dcf5bf5399b681e8853511105441769ba","claim":"Keenova Therapeutics plc shareholders approved Approve the reduction of Company capital (Special Resolution) at the 2026-06-02 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 25,256,218 35,379 191,295 310,829","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"},{"claim_id":"cc857afbbe9e1aac3bd306659f44279d68ab56fa","claim":"Keenova Therapeutics plc shareholders approved Approve an amendment to the Company's articles of association (Special Resolution) at the 2026-06-02 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 25,476,547 6,345 0 310,829","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926069792/0001104659-26-069792-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-02"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}